The Cardiovascular Prevention Program

Cardiovascular diseases represent one of the main public health problems being the leading cause of morbidity, disability and mortality. In recent decades, the global prevalence and cardiovascular disease mortality has increased, with 23.6 million annual deaths expected by 2030. In Europe, mortality per year is equal to 2.2 million women and 1.9 million men, representing 47% and 37% of all deaths respectively. In Italy, the situation in terms of deaths due to cardiovascular diseases it is in line with the world ranking and European, being responsible for 44% of all deaths. The only interventional or pharmacological approach is neither effective nor sustainable. The most deaths from cardiovascular diseases are due to atherothrombotic events, which are attributable to a series of risk factors, most of which are modifiable. Turns out itself as a targeted action on these factors with the aim of safeguarding the state of health cardiovascular, may represent the best applicable strategy. It is therefore necessary structure and activate prevention programs aimed at the general population and groups of subjects at higher risk.

NCT Number	NCT06362538
Lead Sponsor	Maria Cecilia Hospital
Conditions	Cardiovascular Prevention
Enrollment	150 participants
Start Date	2024-05-13
Primary Completion	2027-04-15 (estimated)
Study Completion	2027-04-15 (estimated)
Updated on ClinicalTrials.gov	2024-08-28